{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:27:17Z","timestamp":1759530437290},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1984,12,1]],"date-time":"1984-12-01T00:00:00Z","timestamp":470707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatr Neurol Sci"],"published-print":{"date-parts":[[1984,12]]},"DOI":"10.1007\/bf00381354","type":"journal-article","created":{"date-parts":[[2004,11,7]],"date-time":"2004-11-07T16:40:32Z","timestamp":1099845632000},"page":"231-236","source":"Crossref","is-referenced-by-count":39,"title":["Haloperidol plasma levels and clinical response in paranoid schizophrenics"],"prefix":"10.1007","volume":"234","author":[{"given":"Paul","family":"Linkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Hubain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remy","family":"Frenckell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Mendlewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00433802","volume":"72","author":"B Angrist","year":"1980","unstructured":"Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative vs positive symptoms in schizophrenia. Psychopharmacology 72:17?19","journal-title":"Psychopharmacology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00427590","volume":"67","author":"N Bjorndal","year":"1980","unstructured":"Bjorndal N, Bjerre M, Gerlach J, Kristjansen P, Magelund G, Oestrich IH, Wahrens J (1980) High dosage haloperidol therapy in chronic schizophrenic patients. A double blind study of clinical response, side effects, serum haloperidol and serum prolactin. Psychopharmacology 67:17?22","journal-title":"Psychopharmacology"},{"key":"CR3","first-page":"477","volume":"14","author":"DP Bobon","year":"1981","unstructured":"Bobon DP, Mendlewicz J (1981) R\u00e9sultats pr\u00e9liminaires de l'adaptation fran\u00e7aise de l'\u00e9chelle de schizophrenic de Montgomery. Les feuillets psychiatriques de Liege 14:477?486","journal-title":"Les feuillets psychiatriques de Liege"},{"key":"CR4","volume-title":"Time series analysis: forecasting and control","author":"GEP Box","year":"1976","unstructured":"Box GEP, Jenkins GM (1976) Time series analysis: forecasting and control, revised edition. Holden and Day, San Francisco","edition":"revised edition"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-1781(79)90026-X","volume":"1","author":"HM Calil","year":"1979","unstructured":"Calil HM, Avery DH, Hollister LE, Creese I, Snyder SH (1979) Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations. Psychiatr Res 1:39?44","journal-title":"Psychiatr Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/ajp.135.2.164","volume":"135","author":"A Carlsson","year":"1978","unstructured":"Carlsson A (1978) Antipsychotic drugs, neurotransmitters and schizophrenia. Am J Psychiatry 135:164?173","journal-title":"Am J Psychiatry"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0024-3205(81)90143-0","volume":"28","author":"AJ Cross","year":"1980","unstructured":"Cross AJ, Joseph MH (1980) The current estimation of the major monoamine metabolites in human and non primate brain by HPLC with fluorescence and electrochemical detection. Life Sci 28:499?505","journal-title":"Life Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0033291700050893","volume":"13","author":"JC Cookson","year":"1983","unstructured":"Cookson JC, Moult PJA, Wiles D, Besser GM (1983) The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol. Psychol Med 13:279?285","journal-title":"Psychol Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.280.6207.66","volume":"280","author":"TJ Crow","year":"1980","unstructured":"Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process. Br Med J 280:66?68","journal-title":"Br Med J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(76)91807-9","volume":"II","author":"TJ Crow","year":"1976","unstructured":"Crow TJ, Johnstone EC, Deakin JFW, Longden A (1976) Dopamine and schizophrenia. Lancet II:563?566","journal-title":"Lancet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1176\/ajp.133.2.208","volume":"133","author":"JM Davis","year":"1976","unstructured":"Davis JM (1976) Recent developments in the drug treatment of schizophrenia. Am J Psychiatry 133:208?214","journal-title":"Am J Psychiatry"},{"key":"CR12","volume-title":"BMDP Statistical software 1981","year":"1981","unstructured":"Dixon WJ, Brown MB (eds) (1981) BMDP Statistical software 1981. University of California Press, Berkeley, Calif"},{"key":"CR13","volume-title":"Applied statistics: Analysis of variance and regression","author":"OJ Dunn","year":"1974","unstructured":"Dunn OJ, Clarks VA (1974) Applied statistics: Analysis of variance and regression. John Wiley and Sons, New York"},{"key":"CR14","first-page":"606","volume":"21","author":"A Forssman","year":"1977","unstructured":"Forssman A, Ohman R (1977) Applied pharmacokinetics of haloperidol in man. Curr Ther Res 21:606?617","journal-title":"Curr Ther Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0010-440X(75)80002-2","volume":"16","author":"LA Gottschalk","year":"1975","unstructured":"Gottschalk LA, Biener R, Noble EP (1975) Thioridazime plasma levels and clinical response. Compreh Psychiatry 16:323?337","journal-title":"Compreh Psychiatry"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archpsyc.1978.01770250110011","volume":"35","author":"PH Gruen","year":"1978","unstructured":"Gruen PH, Sachar EJ, Langer G, Attman N, Leifer M, Frantz Z, Halpern FS (1978) Prolactin response in normal and schizophrenic subjects. Arch Gen Psychiatry 35:108?113","journal-title":"Arch Gen Psychiatry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","volume":"II","author":"EC Johnstone","year":"1978","unstructured":"Johnstone EC, Crow TJ, Frith CD, Carney MWP, Price JS (1978) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet II:848?851","journal-title":"Lancet"},{"key":"CR18","first-page":"194","volume":"82","author":"LT Kucharski","year":"1984","unstructured":"Kucharski LT, Alexander P, Tune LC (1984) Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients. Pharmacology 82:194?198","journal-title":"Pharmacology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1210\/jcem-45-5-996","volume":"45","author":"G Langer","year":"1977","unstructured":"Langer G, Sachar EJ, Halpern FS, Gruen PH, Salomon M (1977) The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men. J Clin Endocrinol Metab 45:996?1002","journal-title":"J Clin Endocrinol Metab"},{"key":"CR20","first-page":"1081","volume":"35","author":"JR Magliozzi","year":"1981","unstructured":"Magliozzi JR, Hollister LE, Arnold KV, Earle GM (1981) The relationship of serum haloperidol levels to clinical response in schizophrenic patients. Am J Psychiatry 35:1081?1087","journal-title":"Am J Psychiatry"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00427577","volume":"81","author":"ML Mavroidis","year":"1983","unstructured":"Mavroidis ML, Kanter DR, Hirschowitz J, Garver DL (1983) Clinical response and plasma haloperidol levels in schizophrenia. Psychopharmacology 81:354?356","journal-title":"Psychopharmacology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archpsyc.1976.01770030003001","volume":"33","author":"HY Meltzer","year":"1976","unstructured":"Meltzer HY, Fang US (1976) The effects of neuroleptic on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 33:279?286","journal-title":"Arch Gen Psychiatry"},{"key":"CR23","first-page":"271","volume":"9","author":"HY Meltzer","year":"1983","unstructured":"Meltzer HY, Busch DA, Fang US (1983) Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Psychol Rep 9:271?283","journal-title":"Psychol Rep"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-349-05929-4_21","volume-title":"Clinical pharmacology in psychiatry","author":"J Mendlewicz","year":"1981","unstructured":"Mendlewicz J, Linkowski P, Alexandre J, Schoutens A (1981) Haloperidol plasma levels and clinical response in schizophrenia. In: Usdin E, Dahl SG, Gram LF, Lingjaerde O (eds) Clinical pharmacology in psychiatry. Mac Millan, London, pp 233?237"},{"key":"CR25","volume-title":"Haloperidol radioimmunoassay kit. Instructions for use","author":"M Michiels","year":"1976","unstructured":"Michiels M, Hendriks R, Heykants J (1976) In: Haloperidol radioimmunoassay kit. Instructions for use. IRE (Fleurus), Belgium"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-1019562","volume":"14","author":"HJ Moller","year":"1981","unstructured":"Moller HJ, Kissling W, Maurach R, Schmid P, Doerr P, Pirke K, van Zerssen D (1981) Relationships between serum levels of haloperidol and prolactin, antipsychotic effect and extrapyramidal side effects. Pharmacopsychiatria 14:27?34","journal-title":"Pharmacopsychiatria"},{"key":"CR27","first-page":"1061","volume":"17","author":"SA Montgomery","year":"1978","unstructured":"Montgomery SA, Taylor P, Montgomery D (1978) Development of a schizophrenia scale sensitive to change. Neuropsychopharmacology 17:1061?1963","journal-title":"Neuropsychopharmacology"},{"key":"CR28","first-page":"277","volume-title":"Clinical pharmacology and clinical pharmacy","author":"PL Morselli","year":"1976","unstructured":"Morselli PL (1976) Pediatric clinical pharmacology. Routine monitoring or clinical trial? In: Gouvenia B, Tognoni G, Van der Kleijn E (eds) Clinical pharmacology and clinical pharmacy. Elsevier North Holland, Amsterdam, pp 277?287"},{"key":"CR29","first-page":"877","volume-title":"Neuropsychopharmacology","author":"PL Morselli","year":"1978","unstructured":"Morselli PL (1978) Biological monitoring of psychotropic drugs treatment. In: Deniker P, Radenco-Thomas C, Villeneuve A (eds) Neuropsychopharmacology. Pergama Press, Oxford, pp 877?888"},{"key":"CR30","unstructured":"Morselli PL, Zarifian E (1980) Clinical significance of monitoring plasma levels of psychotropic drugs. In: Drug concentrations in neuropsychiatry. CIBA Foundation Symposium 74, pp 115?128"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00449123","volume":"76","author":"MA Moulin","year":"1982","unstructured":"Moulin MA, Davy JP, De Bruyne D, Andersson JC, Bigot MC, Camsonne R, Poilpre E (1982) Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients. Psychopharmacology 76:346?349","journal-title":"Psychopharmacology"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.1960.03590080086012","volume":"2","author":"National Institute of Mental Health. Psychopharmacology Service Center Collaborative Study group","year":"1960","unstructured":"National Institute of Mental Health. Psychopharmacology Service Center Collaborative Study group (1960) Phenothiazine treatment in acute schizophrenia: Effectiveness. Arch Gen Psychiatry 2:210?220","journal-title":"Arch Gen Psychiatry"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archpsyc.1981.01780270081011","volume":"38","author":"R Neborski","year":"1981","unstructured":"Neborski R, Janowski D, Munson E, Depry D (1981) Rapid treatment of acute psychotic symptoms with high and low haloperidol. Arch Gen Psychiatry 38:195?199","journal-title":"Arch Gen Psychiatry"},{"key":"CR34","first-page":"11","volume":"14","author":"R Ohmann","year":"1978","unstructured":"Ohmann R, Axelson R (1978) Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patients. Eur J Clin Pharmacol 14:11?115","journal-title":"Eur J Clin Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799?805","journal-title":"Psychol Rep"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1192\/bjp.137.6.518","volume":"137","author":"UA Rama Rao","year":"1980","unstructured":"Rama Rao UA, Bishop M, Coppen A (1980) Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. Br J Psychiatr 137:518?521","journal-title":"Br J Psychiatr"},{"key":"CR37","first-page":"112","volume":"35","author":"RW Reschke","year":"1974","unstructured":"Reschke RW (1974) Parenteral haloperidol for rapid control of severe disruptive symptoms of acute schizophrenia. Dis New System 35:112?115","journal-title":"Dis New System"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00429218","volume":"73","author":"A Rimon","year":"1981","unstructured":"Rimon A, Aterbuch I, Roxick S, Fijman-Damilowich L, Kara T, Dasberg H, Ebstein RP, Belmaker RH (1981) Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high dose therapy of resistant schizophrenic patients. Psychopharmacology 73:191?199","journal-title":"Psychopharmacology"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archpsyc.1978.01770330086008","volume":"35","author":"J Rotrosen","year":"1978","unstructured":"Rotrosen J, Angrist BM, Gershon S, Gruen P, Sacha ET, Denning RK, Matthysse S, Stangley M, Wilks S (1978) Thiethylperazime: clinical antipsychotic efficacy and correlation with potency in predictive systems. Arch Gen Psychiatry 35:1112?1118","journal-title":"Arch Gen Psychiatry"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1980.01780220107012","volume":"37","author":"RT Rubin","year":"1980","unstructured":"Rubin RT, Forsman A, Heykants J, Ohman R, Tower B, Michiels M (1980) Serum haloperidol determinations in psychiatric patients. Arch Gen Psychiatry 37:1069?1074","journal-title":"Arch Gen Psychiatry"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004714-198302000-00003","volume":"3","author":"A Shvartsburd","year":"1983","unstructured":"Shvartsburd A, De Kirmenjian H, Smith RC (1983) Blood levels of haloperidol in schizophrenic patients. J Clin Psychopharmacol 3:7?12","journal-title":"J Clin Psychopharmacol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.184.4143.1243","volume":"184","author":"SH Snyder","year":"1974","unstructured":"Snyder SH, Banerjee SP, Yamamura HI, Greenberg D (1974) Drugs, neurotransmitters and schizophrenia. Science 184:1243?1245","journal-title":"Science"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","volume":"35","author":"RL Spitzer","year":"1978","unstructured":"Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35:773?777","journal-title":"Arch Gen Psychiatry"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/ajp.137.2.187","volume":"137","author":"LE Tune","year":"1980","unstructured":"Tune LE, Creese I, De Paulo JR, Slavney PR, Coyle JT, Sneyder S (1980) Clinical state and serum neuroleptic levels measured by radioreceptor assay for schizophrenia. Am J Psychiatry 137:187?190","journal-title":"Am J Psychiatry"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0447.1978.tb06929.x","volume":"58","author":"B Wode-Helgodt","year":"1978","unstructured":"Wode-Helgodt B, Borg S, Fuji R, Sedvall G (1978) Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatr Scand 58:149?158","journal-title":"Acta Psychiatr Scand"}],"container-title":["European Archives of Psychiatry and Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00381354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00381354\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00381354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:34:57Z","timestamp":1554327297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00381354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1984,12]]}},"alternative-id":["BF00381354"],"URL":"https:\/\/doi.org\/10.1007\/bf00381354","relation":{},"ISSN":["0175-758X","1433-8491"],"issn-type":[{"value":"0175-758X","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,12]]}}}